Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

By M. Thompson, J. Aberg, P. Cahn, J. Montaner, G. Rizzardini, A. Telenti, J. Gatell, H. Günthard, S. Hammer, M. Hirsch and 6 more. Journal of the American Medical Association (JAMA), 2008

655 citations recorded by the source corpus.

Subfields: Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/399b87abe6df3dd3e9c4c450320cb95596527303

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Miguel A. Hern'an
2. M. J. van der Laan
3. Peter C. Austin
4. Erica E. Moodie
5. Suchi Saria
6. Yanxun Xu
7. Yanbo Xu

Citations in the corpus

• The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. (2011, background): “Recent guidelines recommend considering antiretroviral therapy initiation when CD4 cell counts decrease to ,500 cells/lL, which would increase the proportion of in-care individuals eligible for treatment [48, 49].”
• Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. (2012, methodology): “As previously recommended, age older than 60 years is an indication to start ART regardless of CD4 cell count.(7) Persons with HIVassociated nephropathy should begin therapy as soon as the diagnosis is made because ART improves survival and kidney function in these patients.”
• Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula (2011, background): “For example, randomized clinical trials have demonstrated that combined antiretroviral therapy (cART) reduces the risk of AIDS and death in HIV-infected patients [4, 8]. However, the optimal time to start cART remains under debate [7, 18, 27 , 28] and no randomized clinical trials have yet been com”